Lessons from the stroke prevention trial in sickle cell anemia (STOP) study

Journal of Child Neurology

Volumn 15, Issue 5, 2000, Pages 344-349

  Adams, Robert J ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; HEMOGLOBIN S;

ADOLESCENT; ARTICLE; CEREBROVASCULAR ACCIDENT; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE PREDISPOSITION; DOPPLER ECHOGRAPHY; DOUBLE BLIND PROCEDURE; ERYTHROCYTE TRANSFUSION; HIGH RISK POPULATION; HUMAN; INTERNAL CAROTID ARTERY OCCLUSION; MAJOR CLINICAL STUDY; MASS SCREENING; MIDDLE CEREBRAL ARTERY OCCLUSION; MULTICENTER STUDY; PRIMARY PREVENTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SICKLE CELL ANEMIA; STROKE;

EID: 0034123430     PISSN: 08830738     EISSN: None     Source Type: Journal    
DOI: 10.1177/088307380001500511     Document Type: Article

References (19)

1. Steinberg MH: Management of sickle cell disease. N Engl J Med 1999;340:1021-1030.
2. Walters MC, Sullivan KM, Bernaudin F, et al: Neurological complications after allogenic bone marrow transplantation for sickle cell anemia. Blood 1995;85:879-884.
3. Charache S, Terrin ML, Moore RD, et al: Effect of hydroxyurea on frequency of painful crises in sickle cell anemia, abstract. N Engl J Med 1995;332:1317.
4. Wayne AS, Kevy SV, Nathan DG: Transfusion management of sickle cell disease. Blood 1993;81:1109-1123.
5. Sydenstricker VP, Mulherin WA, Houseal RW: Sickle cell anemia. Am J Dis Child 1923;26:132-154.
6. Frempong KO, Weiner SJ, Sleeper LA, et al: Cerebrovascular accidents in sickle cell disease: Rates and risk factors. Blood 1998;91:288-294.
7. Rothman SM, Fulling KH, Nelson JS, et al: Sickle cell anemia and central nervous system infarction: A neuropathological study. Ann Neurol 1986;20:684-690.
8. Pegelow CH, Adams RJ, McKie VC, et al: Risk of recurrent stroke in patients with sickle cell disease treated with erythrocyte transfusions. J Pediatr 1995;126:896-899.
9. Adams RJ, Nichols FT, Stephens S, et al: Transcranial Doppler: The influence of age and hematocrit in normal children. J Cardiovasc Ultrasonogr 1988;7:201-205.
10. Adams RJ, Nichols FT, McKie VC, et al: Transcranial Doppler Influence of hematocrit in children with sickle cell anemia without stroke. J Cardiovasc Ultrasonogr 1989;8:97-101.
11. Adams RJ, Nichols FT, Figueroa R, et al: Transcranial Doppler correlation with cerebral angiography in sickle cell disease. Stroke 1992;23:1073-1077.
12. Adams RJ, McKie VC, Nichols FT, et al: The use of transcranial ultrasonography to predict stroke in sickle cell disease. N Engl J Med 1992;326:605-610.
13. Adams RJ, McKie VC, Carl EM, et al: Long-term stroke risk in children with sickle cell disease screened with transcranial Doppler. Ann Neurol 1997;42:699-704.
14. Adams RJ, McKie VC, Brambilla DJ, et al: Stroke prevention trial in sickle cell anemia ("STOP"): Study design. Control Clin Trials 1997;19:110-129.
15. Adams RJ, Brambilla DJ, McKie VC, et al: Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography. N Engl J Med 1998;339:5-11.
16. Adams RJ, Brambilla DJ, McKie VC, et al: Stroke prevention in sickle cell disease (STOP): Follow up after closure of the trial. Blood 1998;92(Suppl):527A.
17. Abboud MR, Cure J, Gallagher D, et al: Magnetic resonance angiography in children with abnormal transcranial Doppler ultrasonograph in the STOP study. Proceedings of the 23rd Annual Meeting of the National Sickle Cell Disease Program, San Francisco, March 1999, p 49.
18. Clinical alert from the National Heart, Lung, and Blood Institute. Dept of Health & Human Services, Sept 18, 1997.
19. Bulas DI, Jones AM, Seibert JJ, et al: Transcranial Doppler screening for stroke prevention in sickle cell anemia: Pitfalls in technique variation. Proceedings of the 42nd Annual Meeting of the Society for Pediatric Radiology, May 14-17, 1999, Vancouver, Canada, abstract 68.